当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 现金流量表

华熙生物

(688363)

  

流通市值:167.14亿  总市值:167.14亿
流通股本:4.82亿   总股本:4.82亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,125,782,095.89887,508,516.44,430,650,311.43,353,715,907.95
  收到的税费返还17,662,635.1815,053,824.3528,084,322.5724,986,150.66
  收到其他与经营活动有关的现金33,530,072.1243,548,482.59241,717,904.3107,753,484.34
  经营活动现金流入小计2,176,974,803.19946,110,823.344,700,452,538.273,486,455,542.95
  购买商品、接受劳务支付的现金382,751,567.75132,655,292.061,071,202,392.66847,703,235.74
  支付给职工以及为职工支付的现金485,066,999.25215,295,501.531,155,171,930.08915,887,663.34
  支付的各项税费136,512,272.474,741,052.58254,128,635.22201,999,259
  支付其他与经营活动有关的现金648,470,007.02392,458,966.491,592,499,647.991,212,106,353.74
  经营活动现金流出小计1,652,800,846.42815,150,812.664,073,002,605.953,177,696,511.82
  经营活动产生的现金流量净额524,173,956.77130,960,010.68627,449,932.32308,759,031.13
二、投资活动产生的现金流量:
  收回投资收到的现金8,574,429.42-128,966.58128,966.58
  取得投资收益收到的现金2,856,555.041,005,657.2410,422,604.96,804,511.99
  处置固定资产、无形资产和其他长期资产收回的现金净额276,215.724,471.12,073,945.552,250,645.55
  收到的其他与投资活动有关的现金512,971,778416,456,100451,000,000331,000,000
  投资活动现金流入小计524,678,978.18417,466,228.34463,625,517.03340,184,124.12
  购建固定资产、无形资产和其他长期资产支付的现金173,481,289.28101,522,084.12325,677,846.28225,471,073.33
  投资支付的现金140,981,603.3913,500,00068,853,353.8142,527,000
  支付其他与投资活动有关的现金783,838,100.55446,456,100333,960,000243,960,000
  投资活动现金流出小计1,098,300,993.22561,478,184.12728,491,200.09511,958,073.33
  投资活动产生的现金流量净额-573,622,015.04-144,011,955.78-264,865,683.06-171,773,949.21
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,200,000-2,520,0002,520,000
  其中:子公司吸收少数股东投资收到的现金4,200,000-2,520,0002,520,000
  取得借款收到的现金67,057,166.6666,665,000310,280,683.61217,460,125
  筹资活动现金流入小计71,257,166.6666,665,000312,800,683.61219,980,125
  偿还债务支付的现金125,810,885.8324,077,596.57202,629,200.48202,212,716.84
  分配股利、利润或偿付利息支付的现金2,748,335.911,315,165.6156,078,754.5654,988,150.48
  支付其他与筹资活动有关的现金26,155,439.966,626,678.4356,392,125.2650,838,125.15
  筹资活动现金流出小计154,714,661.732,019,440.61315,100,080.3308,038,992.47
  筹资活动产生的现金流量净额-83,457,495.0434,645,559.39-2,299,396.69-88,058,867.47
四、汇率变动对现金及现金等价物的影响-16,719,149.77-8,475,867.363,998,656.1211,025,045.21
五、现金及现金等价物净增加额-149,624,703.0813,117,746.93364,283,508.6959,951,259.66
  加:期初现金及现金等价物余额977,775,917.06977,775,917.06613,492,408.37613,492,408.37
  期末现金及现金等价物余额828,151,213.98990,893,663.99977,775,917.06673,443,668.03
补充资料:
  净利润153,164,597.52-291,148,370.39-
  资产减值准备10,501,507.41-108,053,142.71-
  固定资产和投资性房地产折旧158,773,934.81-282,926,828.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧158,773,934.81-282,926,828.17-
  无形资产摊销14,459,595.47-27,260,609.23-
  长期待摊费用摊销17,664,674.54-33,176,989.05-
  处置固定资产、无形资产和其他长期资产的损失-594,407.25--217,334.91-
  固定资产报废损失72,276.08-2,160,447.35-
  公允价值变动损失-1,884,667.39--19,623,286.8-
  财务费用21,572,311.45-2,418,325.03-
  投资损失-23,257,825.62-5,471,394.65-
  递延所得税-15,066,444.14-19,678,789.89-
  其中:递延所得税资产减少-13,835,577.97-20,003,609.71-
    递延所得税负债增加-1,230,866.17--324,819.82-
  存货的减少89,001,883.13-162,150,697.82-
  经营性应收项目的减少26,370,499.63--38,988,841.48-
  经营性应付项目的增加46,747,116.95--327,967,578.94-
  其他---5,283,388.57-
  不涉及现金收支的投资和筹资活动金额其他项目28,432,711.95-41,489,473.44-
  现金的期末余额828,151,213.98-977,775,917.06-
  减:现金的期初余额977,775,917.06-613,492,408.37-
  现金及现金等价物的净增加额-149,624,703.08-364,283,508.69-
公告日期2026-08-282026-04-302026-04-232025-10-29
审计意见(境内)标准无保留意见
TOP↑